Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria

Medecine et Maladies Infectieuses

Volumn 42, Issue 1, 2012, Pages 20-29

  Nedjai, S ^a   Barguigua, A ^b   Djahmi, N ^a   Jamali, L ^b   Zerouali, K ^c   Dekhil, M ^a   Timinouni, M ^b  

^a Centre Hospitalier Universitaire de Annaba   (Algeria)

^b Institut Pasteur du Maroc   (Morocco)

^c Faculté de Médecine et de Pharmacie   (Morocco)

Author keywords

ESBL; KES; Nosocomial infections; Pulsed field gel electrophoresis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; FOSFOMYCIN; GENTAMICIN; NALIDIXIC ACID; SULFAMETHOXAZOLE;

ADULT; AGED; ALGERIA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BETA LACTAMASE CTX M GENE; BETA LACTAMASE SHV GENE; BETA LACTAMASE TEM GENE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTER; EXTENDED SPECTRUM BETA LACTAMASE GENE; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MOLECULAR WEIGHT; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SERRATIA MARCESCENS;

ADULT; ALGERIA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FEMALE; HUMANS; KLEBSIELLA; KLEBSIELLA INFECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHYLOGENY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; R FACTORS; SERRATIA INFECTIONS; SERRATIA MARCESCENS; SUBSTRATE SPECIFICITY; TRANSFORMATION, BACTERIAL; YOUNG ADULT;

EID: 84855848002     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2011.10.001     Document Type: Article

References (41)

1. Gosgrave S.E., Kaye K.S., Eliopoulos G.M., Carmeli Y. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med 2002, 162:207-213.
2. Gniadkowski M. Evolution of Extended-spectrum ß-lactamases by mutation. Clin Microbiol Infect 2008, 14:11-32.
3. Paterson D.L., Bonomo R.A. Extended-spectrum ß-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
4. Essack S.Y. Laboratory detection of extended-spectrum ß-lactamases (ESBLs)-the need for a liables, reproductible method. Diagn Microbiol Infect Dis 2000, 37:293-295.
5. Drieux L., Brossier F., Sougakoff W., Jarlier V. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008, 14(Suppl. 1):90-103.
6. Guessennd N., Bremont S., Gbonon V., Kacou-Ndouba A., Ekaza E., Lambert T., et al. Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Cost. Pathol Biol (Paris) 2008, 56:439-446.
7. Honoré S., Lascols C., Malin D., Targaouchi R., Cattoir V., Legrand P., et al. Investigation of the new qnr based mechanism of quinolone resistance among enterobacterial strains isolated in Henri-Mondor hospital 2002-2005. Pathol Biol (Paris) 2006, 54:270-279.
8. Takahashi S., Nagano Y. Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J Clin Microbiol 1984, 20:608-613.
9. Durmaz R., Otlu B., Koksal F., hosoglu S., Ozturk R., Ersoy Y., et al. The optimisation of rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis 2009, 62:372-377.
10. Alaidan A., Bohol M.F., Al-Thawadi S., Al-Suwaine A., Al-Qahtani A.A., Al-Ahdal M.N. Rapid PFGE method for fingerprinting of Serratia marcescens isolates. J Microbiol Methods 2009, 78(2):238-241.
11. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbio 1995, 33:2233-2239.
12. Auriti C., Liso G.D., Cimmo V.D., Roncheti M.P., Orzalei M. Risk factor for nosocomial infection in a neonatal intensive-care unit. J Hosp Infect 2000, 53:25-30.
13. Peña C., Pujol M., Ricart A., Ardanuy C., Ayats J., Liñares J., et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended-spectrum ß-lactamase (ESBL-Kp) in the intensive care unit. J Hosp Infect 1997, 35:91-96.
14. Rice L.B. Successful interventions for gram-negative resistance to extended-spectrum beta-lactam antibiotics. Pharmacotherapy 1999, 19:120-128.
15. Kim Y.K., Pai H., Lee H.J., Park S.E., Choi E.H., Kim J., et al. Bloodstream infections by extended spectrum ß-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002, 46:1481-1491.
16. Ariffin H., Navaratnam P., Mohamed M., Arasu A., Abdullah W.A., Lee C.L., et al. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia. Int J Infect Dis 2000, 4:21-25.
17. Jacoby G.A. Genetic of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994, 13:2-11.
18. Jacoby G.A. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyiminobeta-lactams. Infect Dis Clin North Am 1997, 11:875-887.
19. Lee E.H., Nicolas M.H., Kitzis M.D., Pialoux G., Collatz E., Gutmann L. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob Agents Chemother 1991, 35:1093-1098.
20. Martinez-Martinez L., Pascual A., Hernandez-Alles S., Alvarez-Diaz D., Suarez A.I., Tran J., et al. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother 1999, 43:1669-1673.
21. Philippon A. Résistance bactérienne: définitions, mécanismes, évolution. EMC (Elsevier Masson SAS, Paris), Maladies infectieuses 2008; 88-006-N-10.
22. Messai Y., Iabadene H., Benhassine T., Alouache S., Tazir M., Gautier V., et al. Prevalence and characterisation of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol Biol 2008, 56:319-325.
23. Babini G.S., Livemore D.M. Antimicrobiol resistance amongst Klebsiella spp collected from intensive care units in southern and western Europe in 1997-1998. J Antimicrob Chemother 2000, 45(2):183-189.
24. Gales A.C., Sader H.S., Jones R.N. Urinary tract infection trends in latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis 2002, 44:289-299. SENTRY Participant Group (Latin America).
25. Labdene H., MessaiY, Ammari H., Ramdani-Bouguessa N., Lounes S., Bakour R., et al. Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother 2008, 62:133-136.
26. Park Y.J., Park S.Y., Oh E.J., Park J.J., Lee K.Y., Woo G.J., et al. Occurence of extended-spectrum betalactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter frendii, and Serratia marcescens in Korea and investigation of screening criteria. Diag Microbiol Infections Dis 2005, 51:265-269.
27. Yang J.L., Wang J.T., Lauderdale T.L., Chang S.C. Prevalence of extended-spectrum β-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum β-lactamase production. J Microbiol Immunol Infect 2009, 42:310-316.
28. Ramazanzadeh R., Chitsaz M., Bahmani N. Prevalence and antimicrobial susceptibility of extended spectrum beta-lactamase-producing bacteria in intensive care units of Sanandaj general hospitals (Kurdistan, Iran). Chemotherapy 2009, 55:287-292.
29. Mamlouk K., Boutiba-Ben Bakour I., Gautie V., Vimont S., Picard B., et al. Emergence and outbreaks of CTX-M extended spectrum beta-lactamase- producing Echerichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol 2006, 44:4049-4059.
30. Ben Achour N., Mercuri P.S., Power P., Belhadj C., BenMoussa M., Galleni M., et al. First detection of CTX-M-28 in a Tunisian hospital from a cefotaxime-resistant Klebsiella pneumoniae strain. Pathol Biol (Paris) 2009, 57:343-348.
31. Canton R., Coque T.M. The CTX-M ß-lactamase pandemic. Curr Opin Microbiol 2006, 9(5):466-475.
32. Livemore D.M., Canton R., Gniadkowski M.P., Rossolini G.M., Arlet G., Ayala J., et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007, 59:165-174.
33. Touati A., Brasme L., Benallaoua S., Gharout A., Madoux J., Champs C. First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals. Diagn Microbiol Infect Dis 2008, 60:287-290.
34. Meradi L., Djahoudi A., Abdi A., Bouchakour M., Perrier Gros Claude J.D., Timinouni M. Qnr and aac (6')-Ib-cr types quinolone resistance among Enterobacteriaceae isolated in Annaba, Algeria. Pathol Biol (Paris) 2011, 59:e73-e78.
35. Canton R., Novais A., Valvedre A., Machado E., Peixe L., Baquero F., et al. Prevalence and spread of extended-spectrum ß-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14(Suppl. 1):144-153.
36. Rossolini G.M., D'Andrea M.M., mugnioli C. The spread of CTX-M-type extended-spectrum ß-lactamases. Clin Microbiol Infect 2008, 14(Suppl. 1):33-41.
37. Hanson N.D., Moland E.S., Hossain A., Neville S.A., Gobell I.B., Thomson K.S. Unusual Salmonella enterica serotype typhimurium isolate producing CMY-7, SHV-9 and OXA-30 betalactamase. J Antimicrob Chemother 2002, 49:1011-1014.
38. Philippon A., Arlet G. Beta-lactamases des bacilles à Gram-négatif le mouvement perpetuel. Ann Biol Clin(Paris) 2005, 64:37-51.
39. Hejazi A., Falkiner F.R. Serratia marcescens. J Med Microbiol 1997, 46:903-912.
40. Tambyah P.A., Maki D.G. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1497 catheterized patients. Arch Med 2000, 160:678-682.
41. Harding G.K., Nicolle L.E., Ronald A.R., Preiksaitis J.K., Forward K.R., Low D.E., et al. How long should catheter-acquired urinary tract infection in woman be treated? A randomized controlled study. Ann Int Med 1991, 114:713-719.